Expired Study
This study is not currently recruiting Study Participants on ClinicalConnection.com. If you would like to find active studies please search for clinical trials.

Long Beach, California 90806


Purpose:

The purpose of this study is to examine the blood levels of two doses of MAP0010 (a corticosteroid) and two doses of an approved corticosteroid in adult asthma and safety with twice daily dosing over 7 days.


Criteria:

Inclusion Criteria: - Male or female adult asthmatics with mild to moderate persistent asthma. - 18 to 45 (up to the 46th birthday) years of age. - Documented diagnosis of asthma at least 3 months prior to Visit 1, per NIH/NHLBI, EPR-3 criteria. - Able to withhold short-acting bronchodilators (e.g., albuterol or ipratropium bromide) for at least 4 hours prior to clinic visits. - Baseline FEV1 greater than or equal to 50% of predicted normal. Exclusion Criteria: - Any other significant illness/abnormality - A history of upper or lower respiratory tract infection within 2 weeks - A history of acute or severe asthma attack requiring ICU admission or ventilatory support.


NCT ID:

NCT00554970


Primary Contact:

N/A


Backup Contact:

N/A


Location Contact:

Long Beach, California 90806
United States



There is no listed contact information for this specific location.

Site Status: N/A


Data Source: ClinicalTrials.gov

Date Processed: August 16, 2017

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.


Click to view Full Listing

This study is not currently recruiting Study Participants on ClinicalConnection.com. The form below is not enabled.